Dianthus Therapeutics, Inc. (DNTH)
NASDAQ·Healthcare·Biotechnology
$83.99
-3.64%
Mkt Cap $3.36B
Analyst Ratings
Buy
14
Hold
0
Sell
0
Price Target (17 analysts)
$109.56
Range $55.00 – $145.00
Implied Upside
+30.4%
Consensus $109.56 vs current $83.99
NASDAQ·Healthcare·Biotechnology
$83.99
-3.64%
Mkt Cap $3.36B
Buy
14
Hold
0
Sell
0
Price Target (17 analysts)
$109.56
Range $55.00 – $145.00
+30.4%
Consensus $109.56 vs current $83.99